| Date | Name | Shares | Transaction | Value |
|
Feb 20, 2026
| Richard A. Silfen Director |
1,890
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 20, 2026
| Shahram Askarpour Chief Executive Officer; Director |
502,442
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 20, 2026
| Shahram Askarpour Chief Executive Officer; Director |
34,364
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 20, 2026
| Shahram Askarpour Chief Executive Officer; Director |
20,171
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 20, 2026
| Jeffrey DiGiovanni Chief Financial Officer |
92,205
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 20, 2026
| Jeffrey DiGiovanni Chief Financial Officer |
16,108
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 20, 2026
| Jeffrey DiGiovanni Chief Financial Officer |
9,455
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jun 25, 2025
| Christopher Harborne |
1,951,241
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $12.5 per share |
24,390,512.50
|
|
Apr 22, 2025
| Roger A. Carolin Director |
77,570
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 22, 2025
| Glen R. Bressner Director |
141,737
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 22, 2025
| Denise L. Devine Director |
20,407
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 22, 2025
| Stephen L. Belland Director |
36,941
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 22, 2025
| Garry Dean Director |
23,790
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|